Evidence map›Paper›PMID 42427876›Full record

ArticleResearch square2026

Grey matter degeneration during multiple sclerosis is linked to activation of neuronal necroptosis by oxidized phosphatidylcholines.

Ruoqi Yu, Jian Park, Qurat Ul Ain, Gaili Yan, Rachel A Dignean, Stephanie Zandee, Wendy Klement, Sandra Larouche, Chao Zheng, Justin J Botterill and 3 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ruoqi YuDepartment of Biochemistry, Microbiology & Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Jian ParkDepartment of Biochemistry, Microbiology & Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Qurat Ul AinDepartment of Biochemistry, Microbiology & Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Gaili YanDepartment of Biochemistry, Microbiology & Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Rachel A DigneanDepartment of Biochemistry, Microbiology & Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Stephanie ZandeeNeuroimmunology Unit, the Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Department of Neuroscience, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada.ORCID 0000-0003-0812-676X
Wendy KlementNeuroimmunology Unit, the Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Department of Neuroscience, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada.
Sandra LaroucheNeuroimmunology Unit, the Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Department of Neuroscience, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada.
Chao ZhengBrain Health Imaging Centre and the Azrieli Centre for Neuro-Radiochemistry at the Centre for Addiction and Mental Health, Departments of Psychiatry, Chemistry, Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Justin J BotterillDepartment of Anatomy, Physiology & Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.ORCID 0000-0002-3141-2281
Alexandre PratNeuroimmunology Unit, the Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Department of Neuroscience, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada.ORCID 0000-0001-6188-0580
Dorian B McGavernViral Immunology and Intravital Imaging Section, National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Health (NIH), Bethesda, MD, USA.
Yifei DongDepartment of Biochemistry, Microbiology & Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.ORCID 0000-0003-1483-2046

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidized phosphatidylcholines (OxPCs) are biomarkers of oxidative stress found in grey matter (GM) lesions during multiple sclerosis (MS), yet their distinct role in GM neurodegeneration remains undefined. Here we report that stereotaxic OxPC deposition in the mouse spinal cord GM induces age dependent neuroinflammation and neurodegeneration. Microglia are the predominant macrophages responding to OxPC induced GM lesions and help to mitigate acute neurodegeneration. Neuronal necroptosis activation in mouse GM lesions and neuronal upregulation of OxPCs and necroptosis activation in MS GM lesions suggest OxPC induced necroptosis promote GM degeneration during MS. In support, necroptosis inhibition ameliorates OxPC induced GM neuron loss. Finally, iron(ii)-containing heme deposition in the GM induces both OxPC formation and neuronal necroptosis activation, suggesting an endogenous upstream mechanism for generating neurotoxic OxPCs. These results highlight a plausible link between heme deposition, lipid peroxidation, and neuronal loss, and that necroptosis inhibition could help prevent GM neurodegeneration during MS.

Identifiers

PMID42427876
PMCPMC13345511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.